Skip to content
Open access

Genetic prediction of colorectal cancer risk in six major ancestries provides insights to streamline practice screening guidelines.

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

A comprehensive genetic prediction of CRC risk provides insights that could streamline screening and prevention guidelines and was strongly associated with early onset CRC risk.

Abstract

Background and objective: Colorectal cancer (CRC) is the third leading cause of cancer deaths worldwide. Early identification of high-risk individuals allows targeted prevention and early detection. Design: We constructed a polygenic risk score (PRS) for CRC risk using data from 1,448,354 individuals (103,401 cases). We evaluated its performance for identifying high-risk individuals in 6 major ancestries. Results: The PRS was strongly associated with CRC risk in Europeans (OR per SD =2.13, 95%CI=1.98-2.28), Africans (OR=1.35, 95%CI=1.11-1.64), Hispanics (OR=1.97, 95%CI =1.48-2.61), East Asians (OR=1.98, 95%CI=1.35-2.91), South Asians (OR=1.85, 95%CI=1.44 -2.37), and Middle Easterners (OR=3.10, 95%CI=1.38-6.95). Europeans in the top 10% genetic risk had 14-fold and 5-fold higher CRC risks compared to the bottom 10% (OR=13.50, 95%CI=8.67-21.00), and average (20-70%) risk groups (OR=4.64, 95%CI=3.89-5.52), respectively. The CRC risk in the top 10% individuals was equivalent to having three affected first degree relatives with CRC diagnosed at any age. Genetically high-risk individuals developed CRC up to 15 years earlier than the average. The PRS was strongly associated with early onset CRC risk e.g. in AFR (OR=3.22, 95%CI=1.79-5.81), and improved its prediction e.g. by 9% beyond clinical predictors in EUR. Conclusion: A comprehensive genetic prediction of CRC risk provides insights that could streamline screening and prevention guidelines.

Read PDF

Similar papers

Open access Aug 2026

Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia

It is shown that PRSs are unlikely to serve as therapeutic biomarkers but support their use for enhanced risk-stratified prevention and incorporation into clinical models may improve risk stratification and support targeted prevention.

Rachel Delahunty, S. M. Silva, A. Pandey et al. · 0 citations
Sep 2026

Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?

It is emphasized that the future effectiveness of PDAC prevention lies in refined risk stratification through universal germline testing, the integration of polygenic and environmental data, and the provision of comprehensive psychosocial support to manage the emotional impact of surveillance.

D. Campa, C. Rizzato, A. Kataki et al. · 0 citations
Review Sep 2026

Screening strategies for colorectal cancer: adjusting for individual risk factors

ABSTRACT Introduction Colorectal cancer (CRC) is a common cause of cancer-related mortality. While overall incidence has declined, certain populations – particularly younger patients – have experienced a rise. This suggests a more complex risk profile than the dichotomous average vs high risk delineated in guidelines....

Kelsey L. Anderson, Sophie Montgomery, A. Winslow et al. · 0 citations
Open access Aug 2026

Age-stratified mutation patterns in early-onset colorectal cancer reveal distinct molecular features and therapeutic implications

Differences in mutations of key genes including a lower prevalence of APC mutations and increased SMAD4 mutations in younger individuals provides further supporting evidence that early-onset CRC may represent a distinct biological subtype of CRC.

L. Liu, A. Rose, A. Samaddar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.